Summit Therapeutics Statistics

Total Valuation

SMMT has a market cap or net worth of $14.12 billion. The enterprise value is $13.89 billion.

Market Cap	14.12B
Enterprise Value	13.89B

Important Dates

The last earnings date was Monday, October 20, 2025, before market open.

Earnings Date	Oct 20, 2025
Ex-Dividend Date	n/a

Share Statistics

SMMT has 771.15 million shares outstanding. The number of shares has increased by 4.36% in one year.

Current Share Class	771.15M
Shares Outstanding	771.15M
Shares Change (YoY)	+4.36%
Shares Change (QoQ)	+0.11%
Owned by Insiders (%)	79.07%
Owned by Institutions (%)	13.59%
Float	129.26M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	70.90
P/TBV Ratio	74.21
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.80, with a Debt / Equity ratio of 0.03.

Current Ratio	3.80
Quick Ratio	3.67
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-103,901.44

Financial Efficiency

Return on equity (ROE) is -292.49% and return on invested capital (ROIC) is -174.95%.

Return on Equity (ROE)	-292.49%
Return on Assets (ROA)	-152.88%
Return on Invested Capital (ROIC)	-174.95%
Return on Capital Employed (ROCE)	-475.16%
Revenue Per Employee	n/a
Profits Per Employee	-$5.80M
Employee Count	159
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +4.03% in the last 52 weeks. The beta is -1.53, so SMMT's price volatility has been lower than the market average.

Beta (5Y)	-1.53
52-Week Price Change	+4.03%
50-Day Moving Average	19.31
200-Day Moving Average	21.98
Relative Strength Index (RSI)	50.81
Average Volume (20 Days)	2,369,743

Short Selling Information

Short Interest	31.24M
Short Previous Month	32.44M
Short % of Shares Out	26.38%
Short % of Float	n/a
Short Ratio (days to cover)	9.18

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-935.11M
Pretax Income	-921.62M
Net Income	-921.62M
EBITDA	-934.99M
EBIT	-935.11M
Earnings Per Share (EPS)	-$1.25

Full Income Statement

Balance Sheet

The company has $238.55 million in cash and $5.43 million in debt, giving a net cash position of $233.13 million or $0.30 per share.

Cash & Cash Equivalents	238.55M
Total Debt	5.43M
Net Cash	233.13M
Net Cash Per Share	$0.30
Equity (Book Value)	192.26M
Book Value Per Share	0.26
Working Capital	181.54M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$269.67 million and capital expenditures -$507,000, giving a free cash flow of -$270.17 million.

Operating Cash Flow	-269.67M
Capital Expenditures	-507,000
Free Cash Flow	-270.17M
FCF Per Share	-$0.35

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

SMMT does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4.36%
Shareholder Yield	-4.36%
Earnings Yield	-6.53%
FCF Yield	-1.91%

Dividend Details

Analyst Forecast

The average price target for SMMT is $33.63, which is 83.67% higher than the current price. The consensus rating is "Buy".

Price Target	$33.63
Price Target Difference	83.67%
Analyst Consensus	Buy
Analyst Count	18
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1